|
1
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnes PJ: Anti-inflammatory actions of
glucocorticoids: Molecular mechanisms. Clin Sci. 94:557–572. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Machein MR, Kullmer J, Ronicke V, Machein
U, Krieg M, Damert A, Breier G, Risau W and Plate KH: Differential
downregulation of vascular endothelial growth factor by
dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol
Appl Neurobiol. 25:104–112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nauck M, Karakiulakis G, Perruchoud AP,
Papakonstantinou E and Roth M: Corticosteroids inhibit the
expression of the vascular endothelial growth factor gene in human
vascular smooth muscle cells. Eur J Pharmacol. 341:309–315. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rutz HP: Effects of corticosteroid use on
treatment of solid tumours. Lancet. 360:1969–1970. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang H, Wang Y, Rayburn ER, Hill DL,
Rinehart JJ and Zhang R: Dexcamethasone as a chemosensitizer for
breast cancer chemotherapy: Potentiation of the antitumor activity
of adriamycin, modulation of cytokine expression, and
pharmacokinetics. Int J Oncol. 30:947–953. 2007.PubMed/NCBI
|
|
7
|
Arafa HM, Abdel-Hamid MA, El-Khouly AA,
Elmazar MM and Osman AM: Enhancement by dexamethasone of the
therapeutic benefits of cisplatin via regulation of tumor
angiogenesis and cell cycle kinetics in a murine tumor paradigm.
Toxicology. 222:103–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yemelyanov A, Czwornog J, Gera L, Joshi S,
Chatterton RT Jr and Budunova I: Novel steroid receptor
phyto-modulator compound a inhibits growth and survival of prostate
cancer cells. Cancer Res. 68:4763–4773. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moghaddam SJ, Haghighi EN, Samiee S,
Shahid N, Keramati AR, Dadgar S and Zali MR: Immunohistochemical
analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in
hepatocellular carcinoma in Iran. World J Gastroenterol.
13:588–593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mamori S, Nagatsuma K, Matsuura T, Ohkawa
K, Hano H, Fukunaga M, Matsushima M, Masui Y, Fushiya N, Onoda H,
et al: Useful detection of CD147 (EMMPRIN) for pathological
diagnosis of early hepatocellular carcinoma in needle biopsy
samples. World J Gastroenterol. 13:2913–2917. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vermeulen PB, Gasparini G, Fox SB, Toi M,
Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL
and Dirix LY: Quantification of angiogenesis in solid human
tumours: An international consensus on the methodology and criteria
of evaluation. Eur J Cancer 32A. 2474–2484. 1996. View Article : Google Scholar
|
|
12
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yano T, Tanikawa S, Fujie T, Masutani M
and Horie T: Vascular endothelial growth factor expression and
neovascularisation in non-small cell lung cancer. Eur J Cancer.
36:601–609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang GL and Semenza GL: Characterization
of hypoxia-inducible factor l and regulation of DNA binding
activity by hypoxia. J Biol Chem. 268:21513–21518. 1993.PubMed/NCBI
|
|
16
|
Ferenci P, Fried M, Labrecque D, Bruix J,
Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA,
et al: Hepatocellular carcinoma (HCC): A global perspective. J Clin
Gastroenterol. 44:239–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Da MX, Wu XT, Wang J, Guo TK, Zhao ZG, Luo
T, Zhang MM and Qian K: Expression of cyclooxygenase-2 and vascular
endothelial growth factor-C correlates with lymphangiogenesis and
lymphatic invasion in human gastric cancer. Arch Med Res. 39:92–99.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martínez A: A new family of angiogenic
factors. Cancer Lett. 236:157–163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jakob C, Sterz J, Zavrski I, Heider U,
Kleeberg L, Fleissner C, Kaiser M and Sezer O: Angiogenesis in
multiple myeloma. Eur J Cancer. 42:1581–1590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pang RW, Joh JW, Johnson PJ, Monden M,
Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann
SurgOncol. 15:962–971. 2008.
|
|
21
|
Barr MP, Bouchier-Hayes DJ and Harmey JJ:
Vascular endothelial growth factor is an autocrine survival factor
for breast tumour cells under hypoxia. Int J Oncol. 32:41–48.
2008.PubMed/NCBI
|
|
22
|
Tzao C, Lee SC, Tung HJ, Hsu HS, Hsu WH,
Sun GH, Yu CP, Jin JS and Cheng YL: Expression of hypoxia-inducible
factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D
as outcome predictors in resected esophageal squamous cell
carcinoma. Dis Markers. 25:141–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin C, McGough R, Aswad B, Block JA and
Terek R: Hypoxia induces HIF-1alpha and VEGF expression in
chondrosarcoma cells and chondrocytes. J Orthop Res. 22:1175–1181.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaelin WG Jr: How oxygen makes its
presence felt. Genes Dev. 16:1441–1445. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Cox SR, Morita T and Kourembanas S:
Hypoxia regulates vascular endothelial growth factor gene
expression in endothelial cells. Identification of a 5′ enhancer.
Circ Res. 77:638–643. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fukumura D and Jain RK: Tumor
microvasculature and microenvironment: Targets for
anti-angiogenesis and normalization. Microvasc Res. 74:72–84. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu S, Yu M, He Y, Xiao L, Wang F, Song C,
Sun S, Ling C and Xu Z: Melittin prevents liver cancer cell
metastasis through inhibition of the Rac1-dependent pathway.
Hepatology. 47:1964–1973. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y, Li XJ, Sui X, Tang XJ, Qin H and
Ren H: Expression and significance of PCNA and Caspase-3 in the
tissue of lung cancer. Xi Bao Yu Fen ZiMian Yi XueZa Zhi.
26:154–156. 2010.(In Chinese).
|
|
29
|
Yang XH and Zou L: Dual functions of DNA
replication forks in checkpoint signaling and PCNA ubiquitination.
Cell Cycle. 8:191–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen H, Feng G, Cui J, Du Q, Qin Y, Cai J,
Shen L and Zhu Y: Clinical implications of serum hypoxia inducible
factor-1á and vascular endothelial growth factor inlung cancer.
Tumori. 101:404–411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Folkman J: Angiogenesis: An organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng KT, Guo DY, Cheng Q, Geng W, Ling CC,
Li CX, Liu XB, Ma YY, Lo CM, Poon RT, et al: A garlic derivative,
S-allylcysteine (SAC), suppresses proliferation and metastasis of
hepatocellular carcinoma. PLoS ONE. 7:e316552012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang L, Tang ZY, Qin LX, Wu XF, Sun HC,
Xue Q and Ye SL: High-dose and long-term therapy with
interferon-alfa inhibits tumor growth and recurrence in nude mice
bearing human hepatocellular carcinoma xenografts with high
metastatic potential. Hepatology. 32:43–48. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bremnes RM, Camps C and Sirera R:
Angiogenesis in non-small cell lung cancer: The prognostic impact
of neoangiogenesis and the cytokines VEGF and bFGF in tumours and
blood. Lung Cancer. 51:143–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liao M, Wang H, Lin Z, Feng J and Zhu D:
Vascular endothelial growth factor and other biological predictors
related to the postoperative survival rate on non-small cell lung
cancer. Lung Cancer. 33:125–132. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ushijima C, Tsukamoto S, Yamazaki K,
Yoshino I, Sugio K and Sugimachi K: High vascularity in the
peripheral region of non-small cell lung cancer tissue is
associated with tumor progression. Lung Cancer. 34:233–241. 2001.
View Article : Google Scholar : PubMed/NCBI
|
